Ultime notizie per Atrium Mortgage (OTC:AMIVF) Azioni

Atrium Mortgage

Atrium Mortgage Inv

Atrium Mortgage Investment Corp is a mortgage investment corporation in Canada. The company is a provider of financing solutions to commercial real estate and development communities in urban centers in Ontario and Western Canada. The company generates its revenue from mortgage interest and fees and rental income.

ATRIUM MORTGAGE INVST CP by Atrium Mortgage Investment Corp

Atrium Mortgage Investment Corp

WIIM

SANW

S&W Seed shares are trading higher after the company announced it has finalized the voluntary plan of administration  process for its subsidiary, S&W Seed Company Australia.

BBB Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBBB#NYSE">TBBB</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.03 by 233.33 percent. The company reported quarterly sales of $784.20 million which beat the analyst consensus estimate of $776.51 million by 0.99 percent.

Earnings

Earnings Beats

News

TBBB

BBB Foods Q3 EPS $0.10 Beats $0.03 Estimate, Sales $784.20M Beat $776.51M Estimate

As previously reported, S&amp;W Australia adopted a voluntary administration process on July 24, 2024, and on October 11, 2024 creditors of S&amp;W Australia approved a proposed Deed of Company Arrangement pursuant to which, among other things, 100% of the shares in S&amp;W Australia would be transferred to Avior Asset Management No. 3 Pty Ltd. The effective date of the DOCA is November 22, 2024.&nbsp;

S&W Seed Finalizes Voluntary Plan Of Administration Process For Subsidiary S&W Australia; On November 22, S&W Entered Settlement Agreement In Exchange For Release From Intercompany Obligations Owed To S&W Australia

SMTC

Semtech shares are trading higher after the company reported better-than-expected Q3 adjusted EPS and sales, and provided Q4 EPS and revenue guidance above analyst estimates.

Semtech shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 guidance with its midpoint above estimates.

Astronics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRO#NASDAQ">ATRO</a>) ("Astronics" or the "Company") today announced that it intends to offer, subject to market and other conditions, $150 million aggregate principal amount of convertible senior notes due 2030 (the "Notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Astronics also expects to grant to the initial purchasers of the Notes an option to purchase up to an additional $15 million aggregate principal amount of the Notes, for settlement within a 13-day period beginning on, and including, the first date on which the Notes are issued.

Offerings

ATRO

Astronics Corporation Announces $150M Convertible Senior Notes Due 2030 Offering

LESL

Leslie's shares are trading lower after the company reported worse-than-expected Q4 adjusted EPS and sales.

CLRO

ClearOne shares are trading higher after the company announced it has engaged ARC Group to explore strategic alternatives, including a merger, sale, or spin-off, to maximize shareholder value. Additionally, board member Larry Hendricks will not seek re-election in 2024.

The Q4 earnings report for Leslies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) was released on Monday, November 25, 2024 at 04:05 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Leslies missed estimated earnings by -82.0%, reporting an EPS of $0.02 versus an estimate of $0.11.
Revenue was down $34.51 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
In the previous quarter, the company missed on EPS by $0.08, resulting in a 14.000000000000002% increase change in the share price the following day.
Here's a look at Leslies's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.42</td>
<td>-0.18</td>
<td>-0.21</td>
<td>0.18</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.34</td>
<td>-0.17</td>
<td>-0.20</td>
<td>0.14</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>615.41M</td>
<td>200.92M</td>
<td>169.61M</td>
<td>419.39M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>569.64M</td>
<td>188.66M</td>
<td>173.96M</td>
<td>432.37M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Leslies <a href="https://www.benzinga.com/quote/LESL/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Leslies Earnings Report: Q4 Overview

Guidance

Leslies Sees Q1 2025 Revenue $169M-$176M Vs $178.41M Estimate; Sees Adj. EPS $(0.21)-$(0.20) Vs $(0.19) Estimate

The Q3 earnings report for Semtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) was released on Monday, November 25, 2024 at 04:15 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Semtech beat estimated earnings by 13.0%, reporting an EPS of $0.26 versus an estimate of $0.23.
Revenue was up $35.90 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
Last quarter the company beat on EPS by $0.02 which was followed by a 11.0% increase in the share price the next day.
Here's a look at Semtech's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.09</td>
<td>0.11</td>
<td>-0.03</td>
<td>-0.13</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.11</td>
<td>0.06</td>
<td>-0.06</td>
<td>0.02</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>212.30M</td>
<td>210.16M</td>
<td>196.46M</td>
<td>204.49M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>215.35M</td>
<td>206.10M</td>
<td>192.95M</td>
<td>200.90M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Semtech <a href="https://www.benzinga.com/quote/SMTC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Semtech: Q3 Earnings Insights

Baird analyst Tristan Gerra initiates coverage on Rambus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) with a Outperform rating and announces Price Target of $90.

Price Target

Initiation

Analyst Ratings

RMBS

Baird Initiates Coverage On Rambus with Outperform Rating, Announces Price Target of $90

BioHarvest Sciences Inc. - Common Stock (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHST#NASDAQ">BHST</a>) reported quarterly losses of $(0.16) per share. This is a 23.08 percent decrease over losses of $(0.13) per share from the same period last year. The company reported $6.54 million in sales this quarter. This is a 101.88 percent increase over sales of $3.24 million the same period last year.

BHST

BioHarvest Sciences Inc. - Common Stock Q3 EPS $(0.16) Down From $(0.13) YoY, Sales $6.54M Up From $3.24M YoY

Baird analyst Joel Beatty initiates coverage on Bright Minds Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRUG#NASDAQ">DRUG</a>) with a Outperform rating and announces Price Target of $75.

DRUG

Baird Initiates Coverage On Bright Minds Biosciences with Outperform Rating, Announces Price Target of $75

Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) announced its Q4 earnings on Monday, November 25, 2024 at 04:02 PM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
Central Garden &amp; Pet beat estimated earnings by 10.0%, reporting an EPS of $-0.18 versus an estimate of $-0.2.
Revenue was down $80.66 million from the same period last year.
<h3>Overview of Past Earnings</h3>
Last quarter the company beat on EPS by $0.11 which was followed by a 6.0% increase in the share price the next day.
Here's a look at Central Garden &amp; Pet's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.21</td>
<td>0.80</td>
<td>-0.14</td>
<td>0.06</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.32</td>
<td>0.99</td>
<td>0.01</td>
<td>0.08</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.00B</td>
<td>887.42M</td>
<td>619.95M</td>
<td>735.32M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>996.35M</td>
<td>900.09M</td>
<td>634.53M</td>
<td>750.15M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Central Garden &amp; Pet <a href="https://www.benzinga.com/quote/CENT/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CENT

Recap: Central Garden & Pet Q4 Earnings

Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) just disclosed its Q4 earnings on Monday, November 25, 2024 at 04:02 PM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
Central Garden &amp; Pet beat estimated earnings by 18.0%, reporting an EPS of $-0.18 versus an estimate of $-0.22.
Revenue was down $80.66 million from the same period last year.
<h3>Previous Earnings Records</h3>
The company beat on EPS by $0.02 in the last quarter, resulting in a 0.0% increase share price change the following day.
Here's a look at Central Garden &amp; Pet's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.20</td>
<td>1.21</td>
<td>0.80</td>
<td>0.76</td>
<td>-0.14</td>
<td>-0.14</td>
<td>0.06</td>
<td>0.06</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.32</td>
<td>1.32</td>
<td>0.99</td>
<td>0.99</td>
<td>0.01</td>
<td>0.01</td>
<td>0.08</td>
<td>0.08</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.00B</td>
<td>1.00B</td>
<td>887.42M</td>
<td>883.42M</td>
<td>619.95M</td>
<td>619.95M</td>
<td>735.32M</td>
<td>735.32M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>996.35M</td>
<td>996.35M</td>
<td>900.09M</td>
<td>900.09M</td>
<td>634.53M</td>
<td>634.53M</td>
<td>750.15M</td>
<td>750.15M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Central Garden &amp; Pet <a href="https://www.benzinga.com/quote/CENTA/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CENTA

Earnings Breakdown: Central Garden & Pet Q4

Fourth Quarter of Fiscal Year 2025 Outlook
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">(in millions, except per share data)</td>
<td colspan="7" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net sales</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">250.0</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">+/-</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$5.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-GAAP Financial Measures</td>
<td colspan="3" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gross margin</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">52.8</td>
<td colspan="1" rowspan="1">%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">+/-</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">50 bps</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Operating expenses, net</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">82.8</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">+/-</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$1.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Operating income</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">49.2</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">+/-</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$2.8</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Operating margin</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">19.7</td>
<td colspan="1" rowspan="1">%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">+/-</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">70 bps</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Interest expense, net</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">19.0</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Normalized tax rate</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">15</td>
<td colspan="1" rowspan="1">%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Diluted earnings per share</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">0.32</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">+/-</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$0.03</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">56.9</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">+/-</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$2.8</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA margin</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">22.8</td>
<td colspan="1" rowspan="1">%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">+/-</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">70 bps</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="3" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Diluted share count</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">80.0</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
See "Non-GAAP Financial Measures" below for additional information about our non-GAAP financial results.
The Company is unable to include a reconciliation of forward-looking non-GAAP results to the corresponding GAAP measures as this is not available without unreasonable efforts due to the high variability and low visibility with respect to the impact of transaction, integration and restructuring expenses, share-based awards, amortization of acquisition-related intangible assets and other items that are excluded from these non-GAAP measures. The Company expects the variability of the above charges to have a potentially significant impact on its GAAP financial results.

Semtech Sees Q4 EPS $0.32 +/- $0.03 Vs $0.27 Est.; Revenue $250M +/- $5M Vs $242.03M Est.

Nehama served on the Board of Directors and as the Company's Chairman of the Board since March 2008 and is a controlling shareholder of the Company.
Sheizaf will serve as a director until the Company's 2025 annual general meeting, at which he can be nominated for reappointment to the Company's Board of Directors.

Management

ELLO

Ellomay Capital Says Chairman Shlomo Nehama Has Decided To Resign From Board; Ben Sheizaf Named As Board Member And Chairman

Semtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.23 by 13.04 percent. This is a 1200 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $236.80 million which beat the analyst consensus estimate of $232.06 million by 2.04 percent. This is a 17.87 percent increase over sales of $200.90 million the same period last year.

Semtech Q3 Adj $0.26 Beats $0.23 Estimate, Sales $236.80M Beat $232.06M Estimate

<ul>
<li>In 2020, Alibaba Group Holding Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) prepared for the record-breaking IPO of its affiliate, Ant Group, poised to revolutionize financial technology.</li>
<li>Just days before the launch, regulators revealed that Ant had bypassed key banking laws to expand its services.</li>
<li>The IPO, valued at $35 billion, was abruptly suspended, causing Alibaba's stock to plummet 13% in a single day.</li>
<li>Shortly after, the State Administration for Market Regulation launched an antitrust investigation into Alibaba's monopolistic practices.</li>
<li>Investors alleged that Alibaba misled them about regulatory risks tied to Ant Group, its ownership structure, and lending activities.</li>
<li>Alibaba has agreed to a $433.5 million settlement with investors to resolve these claims. Affected investors can now <a href="https://11thestate.com/cases/alibaba-investor-settlement">file a claim</a> to receive their payouts.</li>
</ul>
Overview
In July 2020, Ant Group announced plans for a record-breaking $35 billion IPO, poised to drive significant growth for Alibaba Group Holding Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), which held a 33% stake. However, regulatory concerns over Ant's business model, ownership structure, and compliance with new fintech rules led to the IPO's abrupt suspension in November, just days before its launch. The fallout caused Alibaba's shares to plummet, erasing billions in market value, and triggered an antitrust investigation into its monopolistic "Choose One of Two" practices. In response, investors filed a class-action lawsuit, accusing Alibaba of failing to disclose critical regulatory risks. Recently, Alibaba agreed to pay $433.5 million to affected shareholders to settle this lawsuit.
SAMR's Crackdown on Alibaba: Legal and Regulatory Implications
As Alibaba's market dominance and access to vast consumer data grew, the Chinese government expressed rising concerns about its economic impact. In response, the SAMR introduced new anti-monopoly regulations on September 1, 2019, targeting practices by powerful companies like Alibaba. 
On November 5, SAMR convened a meeting with around twenty major e-commerce firms, warning that practices like "Choose One of Two" were illegal and must stop.&nbsp;
While Alibaba did not deny using such practices, it dismissed the criticism as "slander" and "malicious hype" in a press statement. Under growing regulatory pressure, however, the company eventually committed to compliance, acknowledging potential scrutiny for future violations.
Despite the clear warnings, Alibaba continued its anti-competitive behavior. In November 2020, the government introduced new regulations specifically targeting monopolistic behavior in the internet industry, with Alibaba as a primary focus. 
This announcement triggered a sharp 9% drop in Alibaba's share price on November 10, 2020. By December, SAMR launched a formal investigation, which ultimately found Alibaba guilty and resulted in a record $2.8 billion fine.&nbsp;
Political Risk and the Hidden Investors Behind Ant&#8217;s IPO
Ant Group was spun off from Alibaba in 2011. Jack Ma controlled 50.5% of Ant's shares, while Alibaba held a 33% stake.&nbsp;
On July 20, 2020, Alibaba announced Ant&#8217;s IPO, aiming to raise a record $35 billion with a $300 billion valuation, sparking excitement among investors, as Alibaba's stake could be worth over $100 billion.&nbsp;
However, the enthusiasm was short-lived, as the company revealed in November 2020 that the IPO had been abruptly suspended.
The suspension was largely driven by Ant's attempt to bypass financial regulations. Although operating as a financial services company, Ant positioned itself as a tech firm to avoid traditional banking rules. Its high-risk lending activities, with leverage ratios of 50-60 times, raised serious concerns among regulators. In response, China introduced new rules in September 2020, requiring financial holding companies like Ant to maintain higher capital levels, further intensifying scrutiny. Jack Ma's criticism of regulators in an October speech further fueled tensions.
Another major risk to the IPO was the hidden identities of private investors whose interests conflicted with those of Chinese President. These investors concealed their ownership through complex and opaque investment structures. Jack Ma was reportedly aware of the political risks tied to these undisclosed ownership interests but failed to address them transparently. When the Chinese government uncovered the identities of these investors during an investigation prior to the Ant IPO, it decided to halt the offering entirely.
As a result of the undisclosed information, the share price of Alibaba dropped from $310 on November 2, 2020, to $222 on December 24, 2020, indicating a total fall of 29%.&nbsp;
Following these events, investors accused Alibaba of failing to disclose the regulatory risks tied to Ant Group and its monopolistic practices, leading to a lawsuit against the company.
Resolving the Case
To resolve the lawsuit from investors, Alibaba has agreed to a cash settlement of $433.5 million. If you invested in Alibaba, you may be eligible to <a href="https://11thestate.com/cases/alibaba-investor-settlement">claim a portion</a> of this settlement to recover your losses.
Despite these efforts, Alibaba&#8217;s stock remains below its peak, trading at $85. 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="355" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/25182447/image-3-1024x355.png" alt="" class="wp-image-3603" style="width:624px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/25182447/image-3-1024x355.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/25182447/image-3-300x104.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/25182447/image-3-768x266.png 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/25182447/image-3.png 1036w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
In August 2024, China's market regulator announced that Alibaba had completed three years of "rectification" for monopolistic behavior. Alibaba called the announcement a "new starting point for development" and pledged to continue fostering the healthy growth of the platform economy.

Markets

General

BABA

The Fall of Ant Group's IPO: Alibaba's Missteps, Legal Battles, and a $433.5M Settlement

Atrium Mortgage Investment declares CAD 0.075 dividend

Atrium Mortgage Investment declares $0.075 dividend

Atrium Mortgage Investment GAAP EPS of C$0.26, revenue of C$24.9M

Atrium Mortgage Investment Corp (AMIVF) is a mortgage investment corporation in Canada. Over the past year, Atrium's share price rose about 3% from $7.88 to $8.12 as of Friday's market close.

Comments

Atrium Mortgage

Notizie

Ultime notizie per Atrium Mortgage (OTC:AMIVF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO